X-Cor Therapeutics announced that it closed a $2.6 million seed financing round to move its technology toward clinical trials. The Boston-based company developing a novel extracorporeal carbon dioxide removal device is a portfolio company of Alira Health’s investment arm, Alira Health Ventures, according to a news release. Alira Health Ventures led the financing round, with […]